Clinical Trial: Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Brief Summary: This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.

Detailed Summary:
Sponsor: Novo Nordisk A/S

Current Primary Outcome:

  • Percentage of subjects reporting vaginal symptoms occuring 'often' and 'frequently'
  • Percentage of subjects reporting 'moderate' and 'severe' vaginal symptoms


Original Primary Outcome: Same as current

Current Secondary Outcome: Adverse events

Original Secondary Outcome: Same as current

Information By: Novo Nordisk A/S

Dates:
Date Received: January 5, 2012
Date Started: April 2006
Date Completion:
Last Updated: February 6, 2017
Last Verified: February 2017